Asian shares on firm footing as vaccine trials resume
2020-09-14 09:03:03 source：Reuters
September 14, 2020
SYDNEY (Reuters) - Asian shares started higher on Monday as hopes of a coronavirus vaccine were rekindled after AstraZeneca resumed its phase-3 trial while sentiment was still cautious ahead of a big week of central bank meetings in UK, Japan and the United States.
MSCI’s broadest index of Asia-Pacific shares outside Japan was up 0.5%, poised for its second straight session of gains.
Australian shares .AXJO climbed 0.2% while Japan's Nikkei .N225 added 0.3%.
Read more: